LIQUID DOSAGE FORMS, METHODS OF MAKING AND USE

1 . A liquid formulation comprising at least one cannabis or cannabis derived compound and a biocompatible liquid.

2 . The liquid formulation as set forth in claim 1 , wherein the cannabis derived compound comprises one or more of a cannabinoid, a terpene, and a terpenoid.

3 . The liquid formulation as set forth in claim 1 , wherein the cannabinoid is selected from the group consisting of Δ9-tetrahydrocannabinolic acid, Δ9-tetrahydrocannabinol, Δ8-tetrahydrocannabinoilic acid, Δ8-tetrahydrocannabinol, cannabidiolic acid, cannabidiol, cannabigerolic acid, cannabigerol, cannabichromenic acid, cannabichromene, cannabinol, Δ9-tetrahydrocannabivarinic acid, Δ9-tetrahydrocannabivarin, cannabigerivarin, cannabidivarin, cannabichromevarin, 11-hydroxy-Δ9-tetrahydrocannabinol, 11-nor-9-carboxy-Δ9-tetrhydrocannabinol and combinations thereof.

4 . The liquid formulation as set forth in claim 1 , wherein the cannabinoid is at least one of cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC).

5 . The liquid formulation as set forth in claim 1 further comprising at least one terpene or terpenoid.

6 . The liquid formulation as set forth in claim 5 , wherein the terpene or terpenoid is selected from the group consisting of citral, menthol, camphor, salvinorin A, ginkgolide and bilobalide, a curcuminoid, beta-caryophyllene, borneol, 1,8-cineole, camphene, humulene, limonene, linalool, myrcene, nerolidol, pulegone, terpinolene, and combinations thereof.

7 . The liquid formulation as set forth in claim 1 further comprising an additive selected from the group consisting of non-cannabis derived terpenes and terpenoids, flavonoids, viscosity modifiers, natural emulsifiers, oils, thickening agents, minerals, acids, bases, vitamins, flavors, colorants, and combinations thereof.

8 . The liquid formulation as set forth in claim 7 comprising a flavonoid selected from the group consisting of genistein, daidzein, glycitein, isoflavanes, isoflavandiols, isoflavenes, coumestans, pterocarpans, apigenin, beta-sitosterol, cannaflavin A, kaempferol, luteolin, orientin, and quercetin.

9 . The liquid formulation as set forth in claim 1 , wherein the biocompatible liquid is selected from the group consisting of water, purified water, distilled water, mineral water, plant oils, glycerin, mineral oil and combinations thereof.

10 . (canceled)

11 . (canceled)

12 . (canceled)

13 . An emulsion comprising at least one cannabis or cannabis derived compound, a carrier oil, and an aqueous solution.

14 . The emulsion as set forth in claim 13 , wherein the carrier oil is selected from the group consisting of ethanol, isopropanol, dimethyl sulfoxide, acetone, ethyl acetate, pentane, heptane, diethyl ether, water, medium-chain triglycerides (MCT oil), medium-chain fatty acids (e.g., caproic acid, caprylic acid, capric acid, lauric acid), long-chain triglycerides (LCT oil), long-chain fatty acids (e.g., myristic acid, palmitic acid, stearic acid, arachidic acid, linoleic acid), glycerine/glycerol, maisine cc, glycerol monolinoleate, coconut oil, corn oil, canola oil, olive oil, avocado oil, vegetable oil, flaxseed oil, palm oil, palm kernel oil, peanut oil, sunflower oil, rice bran oil, safflower oil, jojoba oil, argan oil, grapeseed oil, castor oil, wheat germ oil, peppermint oil, hemp oil, sesame oil, terpenes, terpenoids, beta-myrcene, linalool, α-pinene, beta-pinene, beta-caryophyllene, caryophyllene oxide, α-humulene, nerolidol, D-limonene, L-limonene, para-cymene, eugenol, farnesol, geraniol, phytol, menthol, terpineol, α-terpineol, benzaldehyde, hexyl acetate, methyl salicylate, eucalyptol, ocimene, terpinolene, α-terpinene, isopulegol, guaiol, α-bisabolol and combinations thereof. Other suitable carrier oils include Labrasol, LabrafacLipophile WL 1349, Labrail M1944, Peceol, Plurol Oliqiue CC 497, Transcutol HP, Tween 80, Gelucire 48/16, and combinations thereof.

15 . The emulsion as set forth in claim 13 , wherein the emulsion is a nanoemulsion.

16 . The emulsion as set forth in claim 15 comprising a droplet size of from about 40 nm to about 60 nm.

17 . A method of preparing the liquid formulation as set forth in claim 1 , the method comprising: mixing at least one cannabis or cannabis derived compound and a biocompatible liquid.

18 . The method as set forth in claim 17 , wherein the mixing comprises one or more process selected from the group consisting of homogenization, microfluidization, high-amplitude ultrasonic processing, and ultrasound-assisted emulsification.

19 . The method as set forth in claim 17 , wherein the cannabis derived compound comprises one or more of a cannabinoid, a terpene, and a terpenoid.

20 . The method as set forth in claim 19 , wherein the cannabinoid is selected from the group consisting of Δ9-tetrahydrocannabinolic acid, Δ9-tetrahydrocannabinol, Δ8-tetrahydrocannabinoilic acid, Δ8-tetrahydrocannabinol, cannabidiolic acid, cannabidiol, cannabigerolic acid, cannabigerol, cannabichromenic acid, cannabichromene, cannabinol, Δ9-tetrahydrocannabivarinic acid, Δ9-tetrahydrocannabivarin, cannabigerivarin, cannabidivarin, cannabichromevarin, 11-hydroxy-Δ9-tetrahydrocannabinol, 11-nor-9-carboxy-Δ9-tetrhydrocannabinol and combinations thereof.

21 . The method as set forth in claim 17 further comprising mixing an additive into the mixture of the at least one cannabis or cannabis derived compound and biocompatible liquid, the additive being selected from the group consisting of non-cannabis derived terpenes and terpenoids, flavonoids, viscosity modifiers, natural emulsifiers, oils, thickening agents, minerals, acids, bases, vitamins, flavors, colorants, and combinations thereof.

22 . The method as set forth in claim 17 , wherein the biocompatible liquid is selected from the group consisting of water, purified water, distilled water, mineral water, plant oils, glycerin, mineral oil and combinations thereof.

23 . (canceled)

24 . (canceled)

25 . The method as set forth in claim 17 further comprising drying the liquid formulation to prepare a powder formulation.